Hulamin (HLM) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
3 Aug, 2026Executive summary
Achieved a strong operational recovery in H1 2026, resolving most challenges from H2 2025 and stabilizing core operations, with production ramping toward design run-rates and a return to normalized profitability.
Completed disposals of non-core extrusions and containers businesses, supporting debt reduction and renewed focus on core operations.
Organizational restructure and specialist appointments completed, driving operational improvements and reliability.
Safety performance improved, driven by a proactive culture and focus on leading indicators.
Financial highlights
Group revenue rose 2% to R7.2 billion, driven by higher LME aluminium prices and improved product mix, despite lower sales volumes.
Normalised trading profit declined 53% to R102 million, mainly due to a stronger rand and lingering operational constraints.
EBITDA more than doubled to R470 million, benefiting from favorable metal price lag.
Net debt increased to R1.7 billion, mainly due to higher working capital from increased LME prices, but remained within all funding covenants.
Positive operating cash flow before capex of R96 million, up from R16 million in the prior period; free cash flow improved to negative R59 million from negative R258 million in H1 2025.
Outlook and guidance
Focus for H2 2026 is on reducing net debt, improving liquidity, and converting operational recovery into cash.
Targeting R100 million from extrusions disposal, R13 million from containers property, and further optimization of inventory and debtors.
Ramp-up to 550 tonnes per day production expected by end of Q4 2026, with further improvement anticipated.
Anticipated margin support from higher global can end pricing, cost reduction, and commercialized Wide Can Body investment.
Cost reduction programme aims for an additional R100 million in H2 2026 and increased scrap utilisation above 27%.
Latest events from Hulamin
- EPS and headline EPS surged over 100% in H1 2026, despite lower normalised headline EPS.HLM
H1 2026 TU31 Jul 2026 - All AGM resolutions passed; board addressed dividends, profitability, and strategic reviews.HLM
AGM 20259 Jul 2026 - All AGM resolutions passed as shareholders pressed for faster turnaround and operational improvements.HLM
AGM 202630 Jun 2026 - Revenue up 8% but normalized EBITDA down 20% amid restructuring and cost pressures.HLM
H1 202530 Mar 2026 - Revenue up 2% but EBIT down 77% amid operational setbacks; recovery expected in 2026.HLM
H2 202528 Mar 2026 - Turnover and EBITDA declined, but local sales and capital investment surged.HLM
H1 202428 Mar 2026 - Normalized EBIT fell 22% year-over-year as strategic CapEx and net debt increased.HLM
H2 202428 Mar 2026